Sponsor Pipeline

Zealand Pharma Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
9
Active Trials
5
Recruiting
4
Phase 3
4
Disease Areas
5
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-13 NCT07197944
Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS
Trial sites expanded: 23 -> 31 locations
2026-08-04 NCT03941236
Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children…
Trial completed
2026-08-04 NCT03941236
Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children…
date change Completion moved earlier: 2026-12-31 -> 2026-05-26
2026-07-31 NCT07228403
Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome
overall status: Enrolling by Invitation → Active, Not Recruiting
2026-07-31 NCT07228403
Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome
Enrollment reduced: 35 -> 28 participants
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-07-29 NCT07733089 A Trial to Understand How Safe and Well Tolerated ZP9830 is and How it Works in People… Phase 1 Recruiting
2026-07-23 NCT07721597 A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability… Early Phase 1 Recruiting
Active Trials by Phase
Phase 3
4
Phase 2
1
Phase 1
3
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07197944 Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS Short Bowel Syndrome Recruiting
NCT03905707 Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS Short Bowel Syndrome Active, Not Recruiting
NCT04881825 Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS… Short Bowel Syndrome Active, Not Recruiting
NCT07228403 Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome Short Bowel Syndrome (SBS) Active, Not Recruiting
Phase 2
NCT06926842 Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2… Overweight Active, Not Recruiting
Phase 1
NCT06682975 A Research Study Looking at the Safety of Single and Multiple Doses of ZP9830 and How it… Healthy Volunteers Recruiting
NCT07682818 Pharmacokinetics of Petrelintide in Participants With Impaired Hepatic Function Impaired Hepatic Function Recruiting
NCT07733089 A Trial to Understand How Safe and Well Tolerated ZP9830 is and How it Works in People… Plaque Psoriasis Recruiting
Early Phase 1
NCT07721597 A Single and Multiple Ascending Dose Trial Assessing Safety, Tolerability… Healthy Participants Study Recruiting
Disease Areas
Get alerts when Zealand Pharma's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free